You are here: Industry Insights > GSK

News List

EMA, GSK blast BMJ’s ‘flawed’ Pandemrix safety report fiercepharma
December 11, 2018
European drug regulatory bodies and GlaxoSmithKline have quickly rallied their rebuttals to a BMJ report that questioned the safety profile of GSK’s now-unavailable pandemic flu vaccine Pandemrix...
M&As : GlaxoSmithKline, Takeda, Procter & Gamble pharmaceutical-technology
December 10, 2018
GlaxoSmithKline (GSK) has agreed to acquire US-based cancer treatment developer Tesaro for $5.1bn.GSK will acquire all issued and outstanding.....
GSK reaches agreement to acquire TESARO, an oncology focused biopharmaceutical company worldpharmanews
December 07, 2018
The proposed transaction will significantly strengthen GSK's pharmaceutical business, accelerating the build of GSK's pipeline and commercial capability in oncology.
GSK enters PARP space with TESARO acquisition pharmaphorum
December 05, 2018
GSK has announced that it will acquire US-based oncology specialist TESARO for $5.1 billion, gaining access to its PARP inhibitor Zejula (niraparib).....
GSK to acquire cancer therapeutics firm Tesaro for $5.1bn pharmaceutical-technology
December 05, 2018
GlaxoSmithKline (GSK) has signed a merger agreement to buy US-based biopharmaceutical company Tesaro for an aggregate consideration of around $5.1bn in a cash-based transaction......
GSK adds to cancer offering with $5.1bn Tesaro buy pharmatimes
December 04, 2018
GlaxoSmithKline is buying US oncology biopharma Tesaro for $5.1 billion, marking the first major purchase by the firm since chief executive Emma Walmsley took charge last year.
GSK begins clinical trials of pancreatic cancer combination pharmaphorum
December 03, 2018
GlaxoSmithKline plans to carry out clinical trials on its pancreatic drug hopeful, GSK547, following promising results when treating mice and laboratory-grown tumour cells.
Vectura takes £40 million hit as asthma drug fails trial pharmaphorum
November 28, 2018
Vectura has abandoned a late-stage drug in severe uncontrolled asthma after it failed a phase 3 trial, resulting in a decline in its already-depressed share price.
Mundipharma appoints former GSK exec as CFO pharmaphorum
November 26, 2018
The Mundipharma network of independent pharma companies has appointed Arnaud Breabout as chief financial officer.
GSK retains leading position on access to medicines list pharmatimes
November 22, 2018
GlaxoSmithKline has retained its top position among a global list of pharmaceutical companies striving to make their medicines, vaccines and diagnostics more accessible for people in low- and middle-income countries.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 40 41 Next page